These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

188 related items for PubMed ID: 11857408

  • 1. CDH1 mutations are present in both ductal and lobular breast cancer, but promoter allelic variants show no detectable breast cancer risk.
    Lei H, Sjöberg-Margolin S, Salahshor S, Werelius B, Jandáková E, Hemminki K, Lindblom A, Vorechovský I.
    Int J Cancer; 2002 Mar 10; 98(2):199-204. PubMed ID: 11857408
    [Abstract] [Full Text] [Related]

  • 2. Epigenetic and genetic alterations of APC and CDH1 genes in lobular breast cancer: relationships with abnormal E-cadherin and catenin expression and microsatellite instability.
    Sarrió D, Moreno-Bueno G, Hardisson D, Sánchez-Estévez C, Guo M, Herman JG, Gamallo C, Esteller M, Palacios J.
    Int J Cancer; 2003 Aug 20; 106(2):208-15. PubMed ID: 12800196
    [Abstract] [Full Text] [Related]

  • 3. CDH1 promoter hypermethylation and E-cadherin protein expression in infiltrating breast cancer.
    Caldeira JR, Prando EC, Quevedo FC, Neto FA, Rainho CA, Rogatto SR.
    BMC Cancer; 2006 Mar 02; 6():48. PubMed ID: 16512896
    [Abstract] [Full Text] [Related]

  • 4. ERBB2 mutation is associated with a worse prognosis in patients with CDH1 altered invasive lobular cancer of the breast.
    Ping Z, Siegal GP, Harada S, Eltoum IE, Youssef M, Shen T, He J, Huang Y, Chen D, Li Y, Bland KI, Chang HR, Shen D.
    Oncotarget; 2016 Dec 06; 7(49):80655-80663. PubMed ID: 27811364
    [Abstract] [Full Text] [Related]

  • 5. CDH1 germline mutations and hereditary lobular breast cancer.
    Corso G, Intra M, Trentin C, Veronesi P, Galimberti V.
    Fam Cancer; 2016 Apr 06; 15(2):215-9. PubMed ID: 26759166
    [Abstract] [Full Text] [Related]

  • 6. The role of E-cadherin in low-grade ductal breast tumourigenesis.
    Roylance R, Droufakou S, Gorman P, Gillett C, Hart IR, Hanby A, Tomlinson I.
    J Pathol; 2003 May 06; 200(1):53-8. PubMed ID: 12692841
    [Abstract] [Full Text] [Related]

  • 7. Germline E-cadherin mutations in familial lobular breast cancer.
    Masciari S, Larsson N, Senz J, Boyd N, Kaurah P, Kandel MJ, Harris LN, Pinheiro HC, Troussard A, Miron P, Tung N, Oliveira C, Collins L, Schnitt S, Garber JE, Huntsman D.
    J Med Genet; 2007 Nov 06; 44(11):726-31. PubMed ID: 17660459
    [Abstract] [Full Text] [Related]

  • 8. E-cadherin and loss of heterozygosity at chromosome 16 in breast carcinogenesis: different genetic pathways in ductal and lobular breast cancer?
    Cleton-Jansen AM.
    Breast Cancer Res; 2002 Nov 06; 4(1):5-8. PubMed ID: 11879552
    [Abstract] [Full Text] [Related]

  • 9. Accuracy of Hereditary Diffuse Gastric Cancer Testing Criteria and Outcomes in Patients With a Germline Mutation in CDH1.
    van der Post RS, Vogelaar IP, Manders P, van der Kolk LE, Cats A, van Hest LP, Sijmons R, Aalfs CM, Ausems MG, Gómez García EB, Wagner A, Hes FJ, Arts N, Mensenkamp AR, van Krieken JH, Hoogerbrugge N, Ligtenberg MJ.
    Gastroenterology; 2015 Oct 06; 149(4):897-906.e19. PubMed ID: 26072394
    [Abstract] [Full Text] [Related]

  • 10. [Effect of genetics, epigenetics and variations in the transcriptional expression of cadherin-E in breast cancer susceptibility].
    Aristizábal-Pachón AF, Takahashi CS.
    Biomedica; 2016 Dec 01; 36(4):593-602. PubMed ID: 27992986
    [Abstract] [Full Text] [Related]

  • 11. Relapsed classic E-cadherin (CDH1)-mutated invasive lobular breast cancer shows a high frequency of HER2 (ERBB2) gene mutations.
    Ross JS, Wang K, Sheehan CE, Boguniewicz AB, Otto G, Downing SR, Sun J, He J, Curran JA, Ali S, Yelensky R, Lipson D, Palmer G, Miller VA, Stephens PJ.
    Clin Cancer Res; 2013 May 15; 19(10):2668-76. PubMed ID: 23575477
    [Abstract] [Full Text] [Related]

  • 12. Epigenetic silencing in non-neoplastic epithelia identifies E-cadherin (CDH1) as a target for chemoprevention of lobular neoplasia.
    Zou D, Yoon HS, Perez D, Weeks RJ, Guilford P, Humar B.
    J Pathol; 2009 Jun 15; 218(2):265-72. PubMed ID: 19294736
    [Abstract] [Full Text] [Related]

  • 13. Frequent E-cadherin gene inactivation by loss of heterozygosity in pleomorphic lobular carcinoma of the breast.
    Palacios J, Sarrió D, García-Macias MC, Bryant B, Sobel ME, Merino MJ.
    Mod Pathol; 2003 Jul 15; 16(7):674-8. PubMed ID: 12861063
    [Abstract] [Full Text] [Related]

  • 14. CDH1 germ-line missense mutation identified by multigene sequencing in a family with no history of diffuse gastric cancer.
    Lajus TB, Sales RM.
    Gene; 2015 Sep 01; 568(2):215-9. PubMed ID: 25981591
    [Abstract] [Full Text] [Related]

  • 15. E-cadherin immunohistochemical expression in invasive lobular carcinoma of the breast: correlation with morphology and CDH1 somatic alterations.
    Grabenstetter A, Mohanty AS, Rana S, Zehir A, Brannon AR, D'Alfonso TM, DeLair DF, Tan LK, Ross DS.
    Hum Pathol; 2020 Aug 01; 102():44-53. PubMed ID: 32599083
    [Abstract] [Full Text] [Related]

  • 16. RASSF1A and CDH1 hypermethylation as potential epimarkers in breast cancer.
    Sebova K, Zmetakova I, Bella V, Kajo K, Stankovicova I, Kajabova V, Krivulcik T, Lasabova Z, Tomka M, Galbavy S, Fridrichova I.
    Cancer Biomark; 2020 Aug 01; 10(1):13-26. PubMed ID: 22297548
    [Abstract] [Full Text] [Related]

  • 17. Nonlobular Invasive Breast Carcinomas with Biallelic Pathogenic CDH1 Somatic Alterations: A Histologic, Immunophenotypic, and Genomic Characterization.
    Derakhshan F, Da Cruz Paula A, Selenica P, da Silva EM, Grabenstetter A, Jalali S, Gazzo AM, Dopeso H, Marra A, Brown DN, Ross DS, Mandelker D, Razavi P, Chandarlapaty S, Wen HY, Brogi E, Zhang H, Weigelt B, Pareja F, Reis-Filho JS.
    Mod Pathol; 2024 Feb 01; 37(2):100375. PubMed ID: 37925055
    [Abstract] [Full Text] [Related]

  • 18. Loss of expression and aberrant methylation of the CDH1 (E-cadherin) gene in breast cancer patients from Kashmir.
    Asiaf A, Ahmad ST, Aziz SA, Malik AA, Rasool Z, Masood A, Zargar MA.
    Asian Pac J Cancer Prev; 2014 Feb 01; 15(15):6397-403. PubMed ID: 25124632
    [Abstract] [Full Text] [Related]

  • 19. The Clonal Relationship Between the Ductal and Lobular Components of Mixed Ductal-Lobular Carcinomas Suggested a Ductal Origin in Most Tumors.
    Pérez-Mies B, Caniego-Casas T, Carretero-Barrio I, Biscuola M, López-García MA, Hardisson D, Rosas M, López Rodríguez MJ, Cristóbal E, Pizarro D, Rosa-Rosa JM, Palacios J.
    Am J Surg Pathol; 2022 Nov 01; 46(11):1545-1553. PubMed ID: 35877198
    [Abstract] [Full Text] [Related]

  • 20. Hereditary lobular breast cancer with an emphasis on E-cadherin genetic defect.
    Corso G, Figueiredo J, La Vecchia C, Veronesi P, Pravettoni G, Macis D, Karam R, Lo Gullo R, Provenzano E, Toesca A, Mazzocco K, Carneiro F, Seruca R, Melo S, Schmitt F, Roviello F, De Scalzi AM, Intra M, Feroce I, De Camilli E, Villardita MG, Trentin C, De Lorenzi F, Bonanni B, Galimberti V.
    J Med Genet; 2018 Jul 01; 55(7):431-441. PubMed ID: 29929997
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.